Flunixin

DB11518

small molecule vet_approved

Deskripsi

Flunixin is a non-steroidal anti-inflammatory drug for use in pigs, cattle and horses. It exerts analgesic and antipyretic effects. This drug is often prepared for use in meglumine salt form. Flunixin is regulated in the United States by the Food and Drug Administration (FDA) and must be prescribed by a licensed veterinarian. Flunixin may be also referred to as Banamine, and other trade names.

Struktur Molekul 2D

Berat 296.249
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1386 Data
Amlodipine Flunixin may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Flunixin.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Flunixin.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Flunixin.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Flunixin.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Flunixin.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Flunixin.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Flunixin.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Flunixin.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Flunixin.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Flunixin.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Flunixin.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Flunixin.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Flunixin.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Flunixin.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Flunixin.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Flunixin.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Flunixin.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Flunixin.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Flunixin.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Flunixin.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Flunixin.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Flunixin.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Flunixin.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Flunixin.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Flunixin.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Flunixin.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Flunixin.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Flunixin.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Flunixin.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Flunixin.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Flunixin.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Flunixin.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Flunixin.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Flunixin.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Flunixin.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Flunixin.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Flunixin.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Flunixin.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Flunixin.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Flunixin.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Flunixin.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Flunixin.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Flunixin.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Flunixin.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Flunixin.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Flunixin.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Flunixin.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Flunixin.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Flunixin.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Flunixin.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Flunixin.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Flunixin.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Flunixin.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Flunixin.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Flunixin.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Flunixin.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Flunixin.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Flunixin.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Flunixin.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Flunixin.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Flunixin.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Flunixin.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Flunixin.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Flunixin.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Flunixin.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Flunixin.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Flunixin.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Flunixin.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Flunixin.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Flunixin.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Flunixin.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Flunixin.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Flunixin.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Flunixin.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Flunixin.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Flunixin.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Flunixin.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Flunixin.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Flunixin.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Flunixin.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Flunixin.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Flunixin.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Flunixin.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Flunixin.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Flunixin.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Flunixin.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Flunixin.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Flunixin.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Flunixin.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Flunixin.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Flunixin.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Flunixin.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Flunixin.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Flunixin.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Flunixin.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Flunixin.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Flunixin.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Flunixin.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Flunixin.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 6474767
    Webbon PM, Woolliscroft GJ: Cautious use of flunixin advocated. Vet Rec. 1984 Jul 14;115(2):45.
  • PMID: 1300683
    Dobromylskyj P: Intraoperative use of flunixin meglumine. Vet Rec. 1992 Nov 28;131(22):520.
  • PMID: 1308097
    Elwood C, Boswood A, Simpson K, Carmichael S: Renal failure after flunixin meglumine administration. Vet Rec. 1992 Jun 27;130(26):582-3.
  • PMID: 3354970
    Traub-Dargatz JL, Bertone JJ, Gould DH, Wrigley RH, Weiser MG, Forney SD: Chronic flunixin meglumine therapy in foals. Am J Vet Res. 1988 Jan;49(1):7-12.
  • PMID: 6416706
    Hardie EM, Kolata RJ, Rawlings CA: Canine septic peritonitis: treatment with flunixin meglumine. Circ Shock. 1983;11(2):159-73.
  • PMID: 3493724
    Jaussaud P: Flunixin and its use in horses. Ann Rech Vet. 1986;17(4):353-62.
  • PMID: 3970431
    Hardie EM, Hardee GE, Rawlings CA: Pharmacokinetics of flunixin meglumine in dogs. Am J Vet Res. 1985 Jan;46(1):235-7.
  • PMID: 850126
    Ciofalo VB, Latranyi MB, Patel JB, Taber RI: Flunixin meglumine: a non-narcotic analgesic. J Pharmacol Exp Ther. 1977 Mar;200(3):501-7.
Menampilkan 8 dari 10 artikel.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul